Pharmacoeconomics-Open

metrics 2024

Transforming Healthcare Through Collaborative Scholarship

Introduction

Pharmacoeconomics-Open, an esteemed journal published by SPRINGER INT PUBL AG, is a vital resource for scholars and practitioners in the fields of health policy and pharmacology. Since its transition to an Open Access platform in 2017, the journal has aimed to democratize access to valuable research, fostering innovation and collaboration globally. With notable rankings in the 2023 Scopus indices—including Q2 in Health Policy and both categories of Pharmacology—Pharmacoeconomics-Open engages with pressing issues in health economics, providing insights into cost-effectiveness analyses and healthcare decision-making. The journal’s commitment to high-quality, peer-reviewed articles ensures that it remains a significant player in advancing knowledge and understanding within its disciplines, serving as an essential forum for researchers, policymakers, and students alike.

Metrics 2024

SCIMAGO Journal Rank0.66
Journal Impact Factor2.00
Journal Impact Factor (5 years)2.00
H-Index20
Journal IF Without Self2.00
Eigen Factor0.00
Normal Eigen Factor0.40
Influence0.73
Immediacy Index0.30
Cited Half Life3.40
Citing Half Life6.70
JCI0.59
Total Documents416
WOS Total Citations678
SCIMAGO Total Citations1518
SCIMAGO SELF Citations36
Scopus Journal Rank0.66
Cites / Document (2 Years)1.94
Cites / Document (3 Years)1.84
Cites / Document (4 Years)1.77

Metrics History

Rank 2024

Scopus

Health Policy in Medicine
Rank #130/310
Percentile 58.06
Quartile Q2
Pharmacology (medical) in Medicine
Rank #144/272
Percentile 47.06
Quartile Q3
Pharmacology in Pharmacology, Toxicology and Pharmaceutics
Rank #191/313
Percentile 38.98
Quartile Q3

IF (Web Of Science)

ECONOMICS
Rank 207/597
Percentile 65.40
Quartile Q2
HEALTH CARE SCIENCES & SERVICES
Rank 91/174
Percentile 48.00
Quartile Q3
HEALTH POLICY & SERVICES
Rank 60/118
Percentile 49.60
Quartile Q3
PHARMACOLOGY & PHARMACY
Rank 222/354
Percentile 37.40
Quartile Q3

JCI (Web Of Science)

ECONOMICS
Rank 253/600
Percentile 57.83
Quartile Q2
HEALTH CARE SCIENCES & SERVICES
Rank 106/175
Percentile 39.43
Quartile Q3
HEALTH POLICY & SERVICES
Rank 80/119
Percentile 32.77
Quartile Q3
PHARMACOLOGY & PHARMACY
Rank 203/354
Percentile 42.66
Quartile Q3

Quartile History

Similar Journals

Gesundheitsoekonomie und Qualitaetsmanagement

Empowering Healthcare Professionals with Quality Management Knowledge
Publisher: THIEME MEDICAL PUBL INCISSN: 1432-2625Frequency: 6 issues/year

Gesundheitsoekonomie und Qualitaetsmanagement, published by THIEME MEDICAL PUBL INC, serves as a vital resource in the field of health policy, particularly within the context of Germany. Since its inception in 1999, this journal has been committed to advancing the discourse on health economics and quality management, making significant contributions to understanding the complexities of healthcare systems. With an impact factor that reflects its ongoing importance, the journal is categorized in the Q4 quartile for Health Policy as of 2023, indicating its role in serving a niche yet crucial space in medical literature. Although currently not an open access journal, it remains accessible through various academic platforms, making its content available to a diverse audience of researchers, healthcare professionals, and students eager to engage with contemporary issues in health economics. With its publication continuing through 2024, Gesundheitsoekonomie und Qualitaetsmanagement is essential for anyone looking to deepen their understanding of the economic aspects of healthcare and ensure quality management in health services.

HEALTH ECONOMICS

Driving change with cutting-edge health economics research.
Publisher: WILEYISSN: 1057-9230Frequency: 12 issues/year

HEALTH ECONOMICS is a premier academic journal published by Wiley, dedicated to advancing the field of health economics. With an ISSN of 1057-9230, this journal has been a vital resource since its inception in 1992, and continues to contribute significantly to the academic landscape as it extends its cover to 2024. With a distinguished ranking of Q1 in Health Policy for 2023, it showcases cutting-edge research and theoretical advancements that inform health policy and economic decision-making globally. The journal features rigorous peer-reviewed articles that address a diverse range of topics within health economics, making it an essential platform for researchers, financial analysts, policymakers, and students alike. Although not an Open Access journal, it strives to ensure accessibility of critical insights for a broad audience, further enhancing its influence within the health economics community.

Expert Review of Pharmacoeconomics & Outcomes Research

Transforming Healthcare Decisions through Insightful Research
Publisher: TAYLOR & FRANCIS LTDISSN: 1473-7167Frequency: 6 issues/year

Expert Review of Pharmacoeconomics & Outcomes Research is a leading journal published by TAYLOR & FRANCIS LTD, focusing on the critical intersection of pharmacoeconomics and healthcare outcomes. Established in 2001, the journal has been a key resource for researchers and professionals in the fields of health policy, medicine, and pharmacology, consistently ranked in the top quartile of these categories for its influential insights. With an ISSN of 1473-7167 and an E-ISSN of 1744-8379, it delivers cutting-edge research that informs healthcare decisions and policy frameworks. The journal's rigorous peer-review process ensures the publication of high-quality, impactful articles that address contemporary challenges and advancements in pharmacoeconomic evaluations. As of 2023, it boasts a commendable ranking of #106 in Health Policy and #124 in Pharmacology, affirming its relevance and contribution to the field. Despite being a subscription-based journal, the strength of its content makes it an invaluable tool for researchers and practitioners aiming to enhance patient outcomes and optimize resource allocation in healthcare systems.

PHARMACOECONOMICS

Empowering informed decisions in healthcare economics.
Publisher: ADIS INT LTDISSN: 1170-7690Frequency: 12 issues/year

PHARMACOECONOMICS, published by ADIS INT LTD, is a prestigious international journal dedicated to disseminating research in the fields of health policy, pharmacology, and public health. With an impressive impact factor and a solid Q1 ranking across its relevant categories, this journal plays a crucial role in shaping policy decisions, optimizing health resources, and enhancing pharmacoeconomic evaluations globally. The journal not only targets researchers and professionals but also serves as an invaluable resource for students striving to understand the economic implications of pharmaceutical care. Operating since 1992 and continuously evolving through 2024, PHARMACOECONOMICS invites contributions that address the complexities of drug expenditure, health outcomes, and public health implications, thereby fostering informed decision-making in healthcare systems. Readers can explore cutting-edge studies and analyses aimed at balancing cost-effectiveness with clinical effectiveness, making this journal a cornerstone for stakeholders invested in the future of health economics.

Cost Effectiveness and Resource Allocation

Unlocking Knowledge for Better Health Economics
Publisher: BMCISSN: 1478-7547Frequency: 1 issue/year

Cost Effectiveness and Resource Allocation is a premier open-access journal published by BMC, dedicated to advancing the field of health policy and economics. Since its inception in 2003, the journal has provided a platform for researchers, policymakers, and healthcare professionals to disseminate crucial findings and insights relevant to cost-effectiveness analyses and resource allocation strategies. With an increasing impact factor and ranking within the Q2 category of health policy journals, it ranks #138 out of 310 in Scopus, placing it in the 55th percentile among its peers. The journal aims to facilitate knowledge exchange that can transform health policy and improve healthcare delivery through rigorous research, evaluation, and dialogue. Open access since its establishment, it ensures that critical findings are available to a global audience, thereby enhancing the impact and reach of its published works.

Journal of Health Economics and Outcomes Research

Exploring the economics of health for a better tomorrow.
Publisher: COLUMBIA DATA ANALYTICS, LLCISSN: 2327-2236Frequency: 1 issue/year

Journal of Health Economics and Outcomes Research, published by COLUMBIA DATA ANALYTICS, LLC, serves as a vital resource in the field of health policy and public health, providing researchers, professionals, and students with open access to pioneering studies since its inception in 2013. With its ISSN and E-ISSN both listed as 2327-2236, this journal aims to disseminate high-quality research that evaluates healthcare efficiency and outcomes. Situated in the United States, at 145 Hudson St., Suite 205, New York, NJ 10013, it has made significant strides in its category quartiles within the 2023 rankings, achieving Q2 status in both Health Policy and Public Health, Environmental and Occupational Health. Furthermore, it maintains respectable Scopus rankings, with a percentile of 51st in health policy and 49th in public health. By bridging gaps in health economics and policy discourse, the journal stands as an indispensable platform for advancing knowledge and fostering innovation in health services research.

BMC HEALTH SERVICES RESEARCH

Advancing health policy through impactful research.
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Health Services Research is a leading open-access journal dedicated to advancing the field of health policy and services research. Published by BMC since 2001 and based in the United Kingdom, this journal has established itself as an essential resource for researchers, professionals, and students alike, fostering a deeper understanding of health care systems and policies. With an impressive 2023 Q1 ranking in the Health Policy category and a Scopus rank of 90/310, it clearly demonstrates its commitment to high-quality, impactful research. The journal's open-access model ensures that research findings are accessible to a global audience, promoting collaboration and innovation in health services. Spanning from 2001 to 2024, BMC Health Services Research is poised to remain at the forefront of health services research, making significant contributions to policy formulation and practice improvement in the healthcare sector.

Applied Health Economics and Health Policy

Unlocking the potential of health economics for global well-being.
Publisher: SPRINGER INT PUBL AGISSN: 1175-5652Frequency: 6 issues/year

Applied Health Economics and Health Policy, published by Springer International Publishing AG, stands as a premier academic journal dedicated to the intersection of economic theory and health policy. With a strong focus on the practical application of economic principles to health issues, this journal addresses crucial topics such as healthcare financing, resource allocation, and economic evaluation of health interventions. Its impressive rankings—in the top quartile for both Health Policy and Medicine, as well as a notable second quartile in Economics—illustrate its significant impact within the fields of health economics and policy research. The journal is aimed at researchers, policymakers, and students who seek to explore innovative solutions to contemporary health challenges. Established in 2002 with ongoing publications through 2024, the journal features open access options that enhance accessibility and engagement with its extensive body of research articles, ensuring that vital insights are available to a global audience.

International Journal of Health Economics and Management

Advancing insights in health economics and management.
Publisher: SPRINGERISSN: 2199-9023Frequency: 4 issues/year

International Journal of Health Economics and Management is a premier academic journal published by SPRINGER, focusing on innovative research at the intersection of health economics and management practices. Established in 2015, this journal caters to a diverse range of disciplines, integrating rigorous economic analysis with vital health policy discussions. With an impressive impact factor reflective of its influential publications, it holds a distinguished Q1 ranking in Economics, Econometrics, and Finance, and a Q2 ranking in Health Policy for 2023. The journal provides an open access model, enabling wider dissemination of research findings to academics, policymakers, and healthcare professionals globally. Researchers and students alike will find this journal invaluable for its commitment to advancing knowledge in health economics and improving healthcare management practices through empirical studies and theoretical insights. For more information, or to access articles, please refer to the journal's platform.

ADVANCES IN THERAPY

Exploring innovative therapies that transform patient care.
Publisher: SPRINGERISSN: 0741-238XFrequency: 12 issues/year

ADVANCES IN THERAPY is a prestigious peer-reviewed journal published by SPRINGER, specializing in the diverse fields of medicine and pharmacology. Established in 1984, this influential journal has become an essential resource for researchers and professionals, boasting a commendable impact factor and categorically ranking within the Q1 quartile in both Medicine (Miscellaneous) and Medical Pharmacology as of 2023. With an impressive Scopus ranking at #52 out of 272 in the realm of medical pharmacology, it places itself in the top 81st percentile, underscoring its importance in advancing therapeutic knowledge and practices. Although the journal is not open access, it provides invaluable insights and the latest research findings in therapies that significantly impact patient care, making it a vital reference for clinicians, academicians, and students alike.